Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaylene J Simpson

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Cell Death and Differentiation|January 7, 2017
Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerizationDaniella Brasacchio, Amber E Alsop, Tahereh Noori, et al.
Computational and Structural Biotechnology Journal|December 1, 2025
macpie: Scalable workflow for high-throughput transcriptomic profilingNenad Bartonicek, Xin Liu, Laura Twomey, et al.
Plos One|August 8, 2012
Optimized PCR conditions and increased shRNA fold representation improve reproducibility of pooled shRNA screensŽaklina Strezoska, Abel Licon, Josh Haimes, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 12, 2018
A Comprehensive Protocol Resource for Performing Pooled shRNA and CRISPR ScreensLeonie A Cluse, Iva Nikolic, Deborah Knight, et al.
Cell Communication and Signaling : CCS|January 29, 2020
FGFR3 signaling and function in triple negative breast cancerNicole J Chew, Elizabeth V Nguyen, Shih-Ping Su, et al.
Cancers|May 6, 2020
Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library ScreenSugandha Bhatia, Tony Blick, Cletus Pinto, et al.
Scientific Data|September 19, 2024
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian CarcinomaKathleen I Pishas, Karla J Cowley, Marta Llaurado-Fernandez, et al.
Assay and Drug Development Technologies|January 17, 2017
SBI<sup>2</sup> HCS/HCA 3D Imaging: Best Practices and Unmet Needs ColloquiumAnn F Hoffman, Kaylene J Simpson, Peter Horvath, et al.
RNA (New York, N.Y.)|April 17, 2020
Requirement for cleavage factor II<sub>m</sub> in the control of alternative polyadenylation in breast cancer cellsRachael E Turner, Lee M Henneken, Marije Liem-Weits, et al.
The Journal of Pathology|August 2, 2020
GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinomaJovana R Gotovac, David Sh Liu, Michael J Yates, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Cell Death and Differentiation|January 7, 2017
Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerizationDaniella Brasacchio, Amber E Alsop, Tahereh Noori, et al.
Computational and Structural Biotechnology Journal|December 1, 2025
macpie: Scalable workflow for high-throughput transcriptomic profilingNenad Bartonicek, Xin Liu, Laura Twomey, et al.
Plos One|August 8, 2012
Optimized PCR conditions and increased shRNA fold representation improve reproducibility of pooled shRNA screensŽaklina Strezoska, Abel Licon, Josh Haimes, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 12, 2018
A Comprehensive Protocol Resource for Performing Pooled shRNA and CRISPR ScreensLeonie A Cluse, Iva Nikolic, Deborah Knight, et al.
Cell Communication and Signaling : CCS|January 29, 2020
FGFR3 signaling and function in triple negative breast cancerNicole J Chew, Elizabeth V Nguyen, Shih-Ping Su, et al.
Cancers|May 6, 2020
Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library ScreenSugandha Bhatia, Tony Blick, Cletus Pinto, et al.
Scientific Data|September 19, 2024
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian CarcinomaKathleen I Pishas, Karla J Cowley, Marta Llaurado-Fernandez, et al.
Assay and Drug Development Technologies|January 17, 2017
SBI<sup>2</sup> HCS/HCA 3D Imaging: Best Practices and Unmet Needs ColloquiumAnn F Hoffman, Kaylene J Simpson, Peter Horvath, et al.
RNA (New York, N.Y.)|April 17, 2020
Requirement for cleavage factor II<sub>m</sub> in the control of alternative polyadenylation in breast cancer cellsRachael E Turner, Lee M Henneken, Marije Liem-Weits, et al.
The Journal of Pathology|August 2, 2020
GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinomaJovana R Gotovac, David Sh Liu, Michael J Yates, et al.
Pageof 12